We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
Turnover
59%
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.29%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$959M
AUM Growth
+$89.9M
(+10%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$33.3M |
| 2 |
Alcoa
AA
|
+$26.7M |
| 3 |
Crown Holdings
CCK
|
+$18.4M |
| 4 |
The AZEK Co
AZEK
|
+$16.3M |
| 5 |
Intuitive Surgical
ISRG
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe
RNR
|
+$29.6M |
| 2 |
Humana
HUM
|
+$26.5M |
| 3 |
Avery Dennison
AVY
|
+$21.2M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$20.5M |
| 5 |
Arch Capital
ACGL
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.79% |
| 2 | Healthcare | 20.79% |
| 3 | Industrials | 8.56% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Materials | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$487B
| $132M | 13.79% |
365,000
+176,800
| +94% | +$62.8M |
2021 Q4
1 quarter
|
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $94.8M | 9.88% |
+210,000
| New | +$93.5M |
2022 Q1
0 quarters
|
|
3
PUT
iShares Russell 2000 ETF
IWM
$77.5B
| $40M | 4.17% |
195,000
+108,000
| +124% | +$22M |
2021 Q3
2 quarters
|
|
|
4
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.2B
| $38.9M | 4.05% |
+289,100
| New | +$33.3M |
2022 Q1
0 quarters
|
|
5
Amazon
AMZN
$2.75T
| $36.7M | 3.82% |
225,000
+99,260
| +79% | +$15.3M |
2021 Q1
4 quarters
|
|
6
Meta Platforms (Facebook)
META
$1.88T
| $34.2M | 3.56% |
153,605
| – | – |
2019 Q3
10 quarters
|
|
|
7
Alcoa
AA
$10.7B
| $33.1M | 3.45% |
+368,200
| New | +$26.7M |
2022 Q1
0 quarters
|
|
8
Teck Resources
TECK
$32.3B
| $28.3M | 2.95% |
699,850
+340,000
| +94% | +$12.2M |
2021 Q2
3 quarters
|
|
9
United Rentals
URI
$65.2B
| $24.6M | 2.57% |
69,305
+24,188
| +54% | +$7.9M |
2021 Q4
1 quarter
|
|
10
DELISTED
RAPT Therapeutics
RAPT
| $23.9M | 2.49% |
136,040
-7,500
| -5% | -$1.42M |
2020 Q4
5 quarters
|
|
|
11
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $23.7M | 2.47% |
200,000
| – | – |
2021 Q4
1 quarter
|
|
12
APi Group
APG
$17.4B
| $22M | 2.29% |
1,567,692
+37,500
| +2% | +$550K |
2020 Q2
7 quarters
|
|
13
Tandem Diabetes Care
TNDM
$1.15B
| $20M | 2.09% |
172,400
+22,400
| +15% | +$2.62M |
2021 Q3
2 quarters
|
|
|
14
Crown Holdings
CCK
$12.4B
| $19.5M | 2.03% |
+155,665
| New | +$18.4M |
2022 Q1
0 quarters
|
|
15
PUT
Regeneron Pharmaceuticals
REGN
$82B
| $17.5M | 1.82% |
+25,000
| New | +$15.8M |
2022 Q1
0 quarters
|
|
|
16
Intuitive Surgical
ISRG
$151B
| $16.4M | 1.7% |
+54,200
| New | +$15.8M |
2022 Q1
0 quarters
|
|
|
17
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.2M | 1.68% |
136,306
-164,067
| -55% | -$20.5M |
2018 Q1
16 quarters
|
|
18
Tvardi Therapeutics
TVRD
$14.3M
| $14.4M | 1.5% |
32,861
+8,333
| +34% | +$3.42M |
2019 Q2
11 quarters
|
|
19
Charles River Laboratories
CRL
$14.6B
| $14.3M | 1.49% |
+50,200
| New | +$15.5M |
2022 Q1
0 quarters
|
|
|
20
DELISTED
The AZEK Co
AZEK
| $12.9M | 1.34% |
+518,000
| New | +$16.3M |
2022 Q1
0 quarters
|
|
21
WillScot Mobile Mini Holdings
WSC
$2.97B
| $12.8M | 1.33% |
326,029
+69,500
| +27% | +$2.61M |
2021 Q2
3 quarters
|
|
22
Palo Alto Networks
PANW
$303B
| $12M | 1.25% |
115,500
-117,900
| -51% | -$10.6M |
2021 Q4
1 quarter
|
|
|
23
CALL
Tandem Diabetes Care
TNDM
$1.15B
| $11.6M | 1.21% |
+100,000
| New | +$11.7M |
2022 Q1
0 quarters
|
|
24
PUT
AMN Healthcare
AMN
$1.55B
| $10.4M | 1.09% |
+100,000
| New | +$10.4M |
2022 Q1
0 quarters
|
|
25
Guardant Health
GH
$22.3B
| $9.66M | 1.01% |
+145,800
| New | +$9.98M |
2022 Q1
0 quarters
|
|
Similar funds
PHP
ACM
FM
PAMI
SI
ZI
RIA
PC
Kingdon Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Kingdon Capital Management's Q1 2022 filing shows 30 new, 18 increased, 14 reduced and 25 closed positions. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M. The largest sale was RenaissanceRe, an estimated $29.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
- Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
- Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
- Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
- Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
- Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
- Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.
Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.